Boca Raton, FL5 Active Studies

Atopic Dermatitis Clinical Trials in Boca Raton, FL

Find 5 actively recruiting atopic dermatitis clinical trials in Boca Raton, FL. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,480
Enrolling

Recruiting Atopic Dermatitis Studies in Boca Raton

NCT06461897Recruiting

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin may not be enough to control the AD in trial parti...

Boca Raton, FLPHASE3675 participantsAbbVie
View Study Details
NCT07228390Recruiting

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

The purpose of this study is to learn about the safety and effects of the study medicine (called Ritlecitinib) for the possible treatment of hidradenitis suppurativa (HS). HS is a disease causing long...

Boca Raton, FLPHASE2240 participantsPfizer
View Study Details
NCT07105488Recruiting

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo....

Boca Raton, FLPHASE2225 participantsBluefin Biomedicine, Inc.
View Study Details
NCT07265479Recruiting

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 23 months (inclusive) with atopic dermatitis....

Boca Raton, FLPHASE3180 participantsOrganon and Co
View Study Details
NCT07277660Recruiting

A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

The purpose of the study is to evaluate the dose-response relationship of galvokimig compared with placebo in study participants with moderate-to-severe atopic dermatitis (AtD)....

Boca Raton, FLPHASE2160 participantsUCB Biopharma SRL
View Study Details

About Atopic Dermatitis Clinical Trials in Boca Raton

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 5 atopic dermatitis clinical trials recruiting participants in Boca Raton, FL. These studies are seeking a combined 1,480 participants. Research is being sponsored by AbbVie, Pfizer, Bluefin Biomedicine, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Boca Raton — FAQ

Are there atopic dermatitis clinical trials in Boca Raton?

Yes, there are 5 atopic dermatitis clinical trials currently recruiting in Boca Raton, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boca Raton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boca Raton research site will contact you about next steps.

Are clinical trials in Boca Raton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boca Raton studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 5 active trials in Boca Raton are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated July 19, 2026 from ClinicalTrials.gov